Aprea Therapeutics (APRE) Non-Current Assets (2018 - 2026)
Aprea Therapeutics (APRE) recorded Non-Current Assets of $376,810 in Q2 2026, down 1.5% from $382,500 a year earlier but up 2.7% from the prior quarter.
Aprea Therapeutics (APRE) Non-Current Assets (2018 - 2026) Analysis & Trends
At the end of FY2025, Aprea Therapeutics reported Non-Current Assets of $372,155, down 7.7% from FY2024.
- Annual Non-Current Assets has a five-year compound annual growth rate of -0.9% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $403,354 in FY2024 (+212.5%), $129,079 in FY2023, $2,321 in FY2022 (-99.0%) and $239,053 in FY2021 (-38.5%).
- Quarterly Non-Current Assets has ranged from $1,912 in Q1 2023 to $410,149 in Q3 2024 over the past five years.
- On a year-over-year basis, Non-Current Assets has declined for five consecutive quarters, with growth averaging 75.5% over the last eight quarters.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 866.9% in Q2 2024, against a decline of 99.3% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $366,947 (Q1 2026), $372,155 (Q4 2025) and $377,328 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Aprea Therapeutics | 40.11 Mn | 40.11 Mn | - | 376,810.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 376,810.00 |
| Mar 31, 2026 | 366,947.00 |
| Dec 31, 2025 | 372,155.00 |
| Sep 30, 2025 | 377,328.00 |
| Jun 30, 2025 | 382,500.00 |
| Mar 31, 2025 | 387,673.00 |
| Dec 31, 2024 | 403,354.00 |
| Sep 30, 2024 | 410,149.00 |
| Jun 30, 2024 | 404,801.00 |
| Mar 31, 2024 | 131,169.00 |
| Dec 31, 2023 | 129,079.00 |
| Sep 30, 2023 | 126,647.00 |
| Jun 30, 2023 | 41,867.00 |
| Mar 31, 2023 | 1,912.00 |
| Dec 31, 2022 | 2,321.00 |
| Sep 30, 2022 | 148,125.00 |
| Jun 30, 2022 | 220,584.00 |
| Mar 31, 2022 | 292,139.00 |
| Dec 31, 2021 | 239,053.00 |
| Sep 30, 2021 | 305,527.00 |
Aprea Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=APRE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "APRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=APRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();